Prevention of Postoperative Endoscopic Recurrence with Endoscopy-driven Versus Systematic Biological Therapy

Recruiting

Phase 4 — Post-approval study. The treatment has been approved, but researchers continue monitoring it in a large population over time.

Trial locations(28 sites)

Belgium

GZA, Antwerp, Antwerpen

UZA, Edegem, Antwerpen

Erasmus ziekenhuis, Brussels, Brussels Capital

Cliniques Universitaires Saint Luc, Brussels, Brussels Capital

UZ Brussel, Jette, Brussels Capital

CHwapi, Tournai, Henegouwen

ZOL Genk, Genk, Limburg

CHC Montlégia, Liège, Liège

CHU de Liège, Liège, Liège

CHU UCL Namur site Godinne, Yvoir, Namur

AZ Maria Middelares, Ghent, Oost-Vlaanderen

UZ Gent, Ghent, Oost-Vlaanderen

UZ Leuven, Leuven, Vlaams-Brabant

Sint lucas Brugge, Bruges, West-Vlaanderen

AZ Damiaan, Ostend, West-Vlaanderen

OLV Aalst, Aalst

Imeldaziekenhuis, Bonheiden

AZ Klina, Brasschaat

AZ Sint-Jan, Bruges

AZ Sint Lucas, Ghent

Jessa ziekenhuis, Hasselt

AZ Sint Maarten, Mechelen

AZ Delta, Roeselare

Vitaz, Sint-Niklaas

Italy

Humanitas research hospital, Milan, Rozzano MI

IRCCS De Bellis Castellana Grotte, Castellana Grotte

Careggi University Hospital, Florence

IRCCS San Raffael Hospital, Milan